Bone Biologics Corporatio... (BBLG)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.96
0.00 (0.20%)
At close: Jan 17, 2025, 3:38 PM
1.00
4.05%
After-hours Jan 17, 2025, 07:26 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
PE Ratio | -0.13 | 3.40 | -22.58 | -81.42 | -43.38 | n/a | n/a | n/a | n/a | n/a | n/a | -481.3 | n/a | n/a | n/a | -9.22M |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.41 | 0.40 | 5.53 | -10.85 | -12.52 | n/a | n/a | n/a | n/a | n/a | n/a | -73.65 | n/a | n/a | n/a | n/a |
P/FCF Ratio | -0.12 | -0.66 | -29.6 | -347.97 | -45.69 | n/a | n/a | n/a | n/a | n/a | n/a | -769.63 | -21.65M | -2.71M | -25.25M | -5.06M |
P/OCF Ratio | -0.12 | -0.66 | -29.6 | -347.97 | -45.69 | n/a | n/a | n/a | n/a | n/a | n/a | -769.63 | -21.65M | -2.71M | -25.25M | -5.06M |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -0.86 | -0.95 | -1.05 | -0.98 | -0.87 | -0.99 | -1.97 | -0.74 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 4.50 | 3.56 | 66.81 | n/a | 0.05 | 0.11 | 0.83 | 0.29 | 0.97 | 0.73 | 0.02 | 0.00 | n/a | n/a | n/a | n/a |
Current Ratio | 4.50 | 3.33 | 66.81 | n/a | 0.05 | 0.11 | 0.83 | 0.29 | 0.97 | 0.98 | 0.02 | 0.00 | n/a | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -1.37 | -0.83 | -2.51 | -2.27 | -0.59 | -5.63 | -6.41 | -2.15 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -3.08 | 0.12 | -0.24 | 0.13 | 0.29 | 0.52 | 0.84 | 2.44 | 2.44 | 1.20 | 0.19 | 0.15 | n/a | n/a | n/a | n/a |
Return on Assets (ROA) | -2.39 | 0.08 | -0.24 | n/a | -111.1 | -4.26 | -8.86 | -21.61 | -6.67 | -1.16 | -12.4 | -301.93 | n/a | n/a | n/a | n/a |
Return on Capital (ROIC) | -3.24 | -0.62 | -0.17 | 0.06 | 4.47 | 0.32 | 15.81 | 7.59 | 184.64 | 56.46 | 0.12 | 0.09 | n/a | n/a | 0.08 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |